Search Login Register

Experimental Melanoma Summary

Description: Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.

Also Known As: Melanoma, Experimental; Experimental Melanomas; Harding Passey Melanoma; Melanomas, Experimental; B16 Melanomas Show All >>

Networked: 2655 relevant articles (117 outcomes, 271 trials/studies) for this Disease

Key Drugs and Agents for Experimental Melanoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antigens : 14 outcomes 14 studies in 144 results : IBA
  2. DNA (Deoxyribonucleic Acid) : 8 outcomes 5 studies in 86 results : IBA
  3. Interleukin-2 (IL2) : 5 outcomes 8 studies in 57 results : IBA
  4. Monophenol Monooxygenase (Tyrosinase) : 4 outcomes 11 studies in 166 results : IBA
  5. Cyclophosphamide (Cytoxan) : 4 outcomes 8 studies in 46 results : FDA 10 Generic
  6. Doxorubicin (Adriamycin) : 4 outcomes 5 studies in 65 results : FDA 12 Generic
  7. Interleukin-12 (IL 12) : 4 outcomes 5 studies in 30 results : IBA
  8. Liposomes (Liposome) : 4 outcomes 3 studies in 39 results : IBA
  9. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 3 outcomes 3 studies in 29 results : IBA
  10. Interferon-gamma (Interferon, gamma) : 3 outcomes 1 study in 27 results : IBA
Show All >>

Diseases Related to Experimental Melanoma

  1. Neoplasms (Cancer)
  2. Melanoma (Melanoma, Malignant)
  3. Neoplasm Metastasis (Metastasis)
  4. Leukemia L1210
  5. Sarcoma (Soft Tissue Sarcoma)
Show All >>

Key Therapies for Experimental Melanoma

Efficacy Chart >>
  1. Intravenous Injections : 6 outcomes 4 studies in 43 results
  2. Immunotherapy : 4 outcomes 8 studies in 41 results
  3. Heterologous Transplantation (Xenotransplantation) : 2 outcomes 5 studies in 55 results
  4. Injections : 2 outcomes 1 study in 27 results
  5. Oral Administration : 2 outcomes 1 study in 18 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.